Remove 2013 Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

Race to the finish: pharma edges closer to approval with RSV vaccines

Pharmaceutical Technology

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

article thumbnail

Campaigners challenge NHS England’s latest plan to share patient data

pharmaphorum

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

Employing MALDI-TOF MS for microbial identification in sterile drug manufacturing Fungal contamination in pharmaceutical cleaning facilities Case study examples Mould and yeast have been reported by several previous authors in numerous pharmaceutical cleanrooms , cold rooms, and controlled areas, according to the authors. Ahmed et al.

article thumbnail

Pharmaceutical microbiology: key developments 2022

European Pharmaceutical Review

” Tony Cundell: Contract manufacturing organisations (CROs), start-up companies, established pharmaceutical companies and regulatory agencies are having difficulty recruiting and retaining technically-trained personnel. The previous record for vaccine development and approval was four years for the measles vaccine.

Vaccines 128
article thumbnail

Top 20 BioPharma Companies Based on 2022 Total Revenue

PharmaShots

Total Revenue: $28.54B Founded Year: 1876 Total Employees: ~21,000 Headquarters: Indianapolis, United States Market Cap: $344.98B Stock Exchange: NYSE With an idea to produce quality products, Eli Lilly and Company is an American Pharmaceutical company focused on discovering, developing, manufacturing, and marketing these products.

article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. The US accounts for almost half of all biotechnology patents filed worldwide from 1999 to 2013. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures.